0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Usc/norris Comprehensive Cancer Center
Los Angeles, California, United States
- Mercy Research Institute
Miami, Florida, United States
- University of Miami
Miami, Florida, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Maryland Greenebaum Cancer Center
Baltimore, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of New Mexico Cancer Center
Albuquerque, New Mexico, United States
- Weill Medical Cornell University
New York, New York, United States
- Stony Brook Cancer Center (suny)
Stony Brook, New York, United States
- Providence Portland Medical Center
Portland, Oregon, United States
- Abramson Cancer Center of Uof Pennsylvania
Philadelphia, Pennsylvania, United States
- West Virginia University Clinical Trials Research Unit
Morgantown, West Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2008
- Primary completion
- 31 May 2012
- Completion
- 31 Dec 2014
- Last update posted
- 30 Oct 2019
- Registered enrollment
- 109
- Registry id
- NCT00771953
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.